ATE486958T1 - Verfahren zur bestimmung von nukleinsäuresequenzen in urin - Google Patents
Verfahren zur bestimmung von nukleinsäuresequenzen in urinInfo
- Publication number
- ATE486958T1 ATE486958T1 AT05077010T AT05077010T ATE486958T1 AT E486958 T1 ATE486958 T1 AT E486958T1 AT 05077010 T AT05077010 T AT 05077010T AT 05077010 T AT05077010 T AT 05077010T AT E486958 T1 ATE486958 T1 AT E486958T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- acid sequence
- urine sample
- urine
- acid sequences
- Prior art date
Links
- 150000007523 nucleic acids Chemical group 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 5
- 210000002700 urine Anatomy 0.000 title abstract 5
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 230000004888 barrier function Effects 0.000 abstract 2
- 210000003734 kidney Anatomy 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4817097P | 1997-05-30 | 1997-05-30 | |
| US4838197P | 1997-06-30 | 1997-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE486958T1 true ATE486958T1 (de) | 2010-11-15 |
Family
ID=26725864
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05077010T ATE486958T1 (de) | 1997-05-30 | 1998-05-29 | Verfahren zur bestimmung von nukleinsäuresequenzen in urin |
| AT10161334T ATE557103T1 (de) | 1997-05-30 | 1998-05-29 | Verfahren zur erkennung von nukleinsäuresequenzen in urin |
| AT98924998T ATE320505T1 (de) | 1997-05-30 | 1998-05-29 | Verfahren zur bestimmung von nukleinsäuresequenzen in urin |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT10161334T ATE557103T1 (de) | 1997-05-30 | 1998-05-29 | Verfahren zur erkennung von nukleinsäuresequenzen in urin |
| AT98924998T ATE320505T1 (de) | 1997-05-30 | 1998-05-29 | Verfahren zur bestimmung von nukleinsäuresequenzen in urin |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6251638B1 (de) |
| EP (3) | EP0920539B9 (de) |
| AT (3) | ATE486958T1 (de) |
| AU (1) | AU7703998A (de) |
| CY (1) | CY1113124T1 (de) |
| DE (2) | DE69833856T2 (de) |
| DK (3) | DK0920539T3 (de) |
| ES (3) | ES2260837T3 (de) |
| PT (1) | PT2216416E (de) |
| WO (1) | WO1998054364A1 (de) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6451523B1 (en) * | 1994-09-14 | 2002-09-17 | Interneuron Pharmaceuticals, Inc. | Detection of a leptin receptor variant and methods for regulating obesity |
| AU7019498A (en) | 1997-04-10 | 1998-10-30 | Diagnocure Inc. | Pca3, pca3 genes, and methods of use |
| USRE39920E1 (en) * | 1997-05-30 | 2007-11-13 | Xenomics, Inc. | Methods for detection of nucleic acid sequences in urine |
| US7060458B1 (en) * | 1997-08-14 | 2006-06-13 | Wyeth | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| US20030104538A1 (en) * | 1997-09-18 | 2003-06-05 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7569342B2 (en) | 1997-12-10 | 2009-08-04 | Sierra Molecular Corp. | Removal of molecular assay interferences |
| US20030068731A1 (en) * | 1997-12-17 | 2003-04-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US20030113842A1 (en) * | 1998-03-11 | 2003-06-19 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7339033B2 (en) * | 1998-06-26 | 2008-03-04 | Genentech, Inc. | Pro1481 |
| US7026448B2 (en) * | 1998-09-01 | 2006-04-11 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2001009324A1 (fr) * | 1999-07-30 | 2001-02-08 | Mitsubishi Pharma Corporation | Gene de pgt de type cerveau humain |
| JP4018304B2 (ja) * | 1999-08-27 | 2007-12-05 | 独立行政法人科学技術振興機構 | 高親和性コリントランスポーター |
| ES2260059T3 (es) | 1999-09-29 | 2006-11-01 | Diagnocure Inc. | Rna mensajero del pca3 en tejidos benignos y malignos de prostata. |
| EP1201681A1 (de) * | 2000-10-30 | 2002-05-02 | Millennium Pharmaceuticals, Inc. | "Fail" Moleküle und deren Verwendung |
| WO2002055985A2 (en) * | 2000-11-15 | 2002-07-18 | Roche Diagnostics Corp | Methods and reagents for identifying rare fetal cells in the material circulation |
| US7029840B2 (en) * | 2000-11-15 | 2006-04-18 | Becton, Dickinson And Company | Method for preservation of cells and nucleic acid targets |
| WO2002059316A2 (en) * | 2001-01-23 | 2002-08-01 | Lexicon Genetics Incorporated | Human ion exchanger proteins and polynucleotides encoding the same |
| US20030144196A1 (en) * | 2001-08-21 | 2003-07-31 | Bowen Michael A. | Activated T lymphocyte nucleic acid sequences and polypeptides encoded by same |
| JP2005514956A (ja) * | 2002-01-18 | 2005-05-26 | ジェンザイム・コーポレーション | 胎児ｄｎａの検出および対立遺伝子の定量化のための方法 |
| WO2003071252A2 (en) * | 2002-02-15 | 2003-08-28 | Exact Sciences Corporation | Methods for analysis of molecular events |
| US7217515B2 (en) * | 2002-09-30 | 2007-05-15 | Chi Mei Foundation Medical Center | HURP gene as a molecular marker for bladder cancer |
| ES2784011T3 (es) | 2002-10-16 | 2020-09-21 | Streck Inc | Procedimiento y dispositivo para recoger y preservar las células para su análisis |
| AU2004209578A1 (en) | 2003-02-07 | 2004-08-19 | Diagnocure Inc. | Method to detect prostate cancer in a sample |
| US20050227225A1 (en) * | 2004-04-07 | 2005-10-13 | Roche Molecular Systems, Inc. | Stabilization of biomolecules in samples |
| US20080241827A1 (en) * | 2004-05-10 | 2008-10-02 | Exact Sciences Corporation | Methods For Detecting A Mutant Nucleic Acid |
| CN101027412B (zh) | 2004-07-23 | 2017-04-26 | 环太平洋生物技术有限公司 | 用于膀胱癌检测的尿标记物 |
| US7981607B2 (en) * | 2004-08-27 | 2011-07-19 | Esoterix Genetic Laboratories LLC | Method for detecting recombinant event |
| CA2585025A1 (en) * | 2004-10-22 | 2006-05-04 | Redpath Integrated Pathology, Inc. | Dynamic genomic deletion expansion and formulation of molecular marker panels for integrated molecular pathology diagnosis and characterization of tissue, cellular fluid, and purefluid specimens |
| US9109256B2 (en) | 2004-10-27 | 2015-08-18 | Esoterix Genetic Laboratories, Llc | Method for monitoring disease progression or recurrence |
| CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
| US7914982B2 (en) * | 2005-02-17 | 2011-03-29 | Trovagene, Inc. | Methods for detecting pathogen specific nucleic acids in urine |
| ITRM20050068A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine. |
| EP2351857B1 (de) | 2005-02-17 | 2014-10-29 | TrovaGene, Inc. | Zusammensetzungen und Verfahren zum Nachweis von für Krankheitserreger spezifischen Nukleinsäuren in Urin |
| ITRM20050067A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine. |
| US7449297B2 (en) * | 2005-04-14 | 2008-11-11 | Euclid Diagnostics Llc | Methods of copying the methylation pattern of DNA during isothermal amplification and microarrays |
| WO2007044071A2 (en) * | 2005-04-21 | 2007-04-19 | Exact Sciences Corporation | Analysis of heterogeneous nucleic acid samples |
| NZ545243A (en) | 2006-02-10 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Urine gene expression ratios for detection of cancer |
| EP2140027B1 (de) * | 2006-12-07 | 2012-07-18 | Novartis AG | Nichtinvasiver pränataler genetischer screen-test |
| WO2008075790A2 (en) * | 2006-12-20 | 2008-06-26 | Olympus Corporation | Method for detecting cancer with nucleic acids in blood |
| ES2660785T3 (es) * | 2007-08-22 | 2018-03-26 | Trovagene, Inc. | Métodos de uso de ARNmi para la detección de la muerte de células in vivo |
| WO2009049147A2 (en) * | 2007-10-10 | 2009-04-16 | Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine | Method of tumor screening by detection of tumour marker in low molecular weight nucleic acid from urine |
| BRPI0908128A2 (pt) * | 2008-02-12 | 2015-08-04 | Novartis Ag | Método para isolamento de ácido nucleicos apoptóticos ou fetais livres de células |
| WO2009114543A2 (en) * | 2008-03-11 | 2009-09-17 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
| EP2853601B1 (de) | 2008-07-18 | 2016-09-21 | TrovaGene, Inc. | Verfahren für den PCR-basierten Nachweis ultrakurzer Nukleinsäuresequenzen |
| US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| US8476013B2 (en) * | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
| EP3290530B1 (de) | 2009-02-18 | 2020-09-02 | Streck Inc. | Konservierung von zellfreien nukleinsäuren |
| CA2780536C (en) * | 2009-11-09 | 2018-01-02 | Streck, Inc. | Stabilization of rna in and extracting from intact cells within a blood sample |
| DK2516680T3 (en) | 2009-12-22 | 2016-05-02 | Sequenom Inc | Method and kits to identify aneuploidy |
| EP2702168B1 (de) | 2011-04-29 | 2018-01-17 | Sequenom, Inc. | Quantifizierung einer minderheitsvariante einer nukleinsäure |
| WO2012151391A2 (en) | 2011-05-04 | 2012-11-08 | Streck, Inc. | Inactivated virus compositions and methods of preparing such compositions |
| US9547748B2 (en) | 2011-06-29 | 2017-01-17 | Bgi Health Service Co., Ltd. | Method for determining fetal chromosomal abnormality |
| US9605313B2 (en) | 2012-03-02 | 2017-03-28 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| EP2872648B1 (de) | 2012-07-13 | 2019-09-04 | Sequenom, Inc. | Verfahren und zusammensetzungen zur methylierungsbasierten anreicherung fetaler nukleinsäure aus einer mütterlichen probe für nicht-invasive pränatale diagnosen |
| US9341628B2 (en) | 2012-11-30 | 2016-05-17 | Interpace Diagnostics Corporation | Methods for measuring carcinoembryonic antigen |
| WO2014168711A1 (en) | 2013-03-13 | 2014-10-16 | Sequenom, Inc. | Primers for dna methylation analysis |
| EP4136972A1 (de) | 2013-07-24 | 2023-02-22 | Streck, Inc. | Zusammensetzungen und verfahren zur stabilisierung zirkulierender tumorzellen |
| US11365447B2 (en) | 2014-03-13 | 2022-06-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2016001411A1 (en) | 2014-07-03 | 2016-01-07 | Multiplicom N.V. | Methods for non-invasive detection of transplant health or rejection |
| US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
| US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
| WO2018022991A1 (en) | 2016-07-29 | 2018-02-01 | Streck, Inc. | Suspension composition for hematology analysis control |
| WO2018064486A1 (en) | 2016-09-29 | 2018-04-05 | Counsyl, Inc. | Noninvasive prenatal screening using dynamic iterative depth optimization |
| US12378543B2 (en) | 2017-10-19 | 2025-08-05 | Streck Llc | Compositions for hemolysis and coagulation regulation and stabilization of extracellular vesicles |
| EP3802857A4 (de) * | 2018-06-07 | 2022-03-09 | BioFire Diagnostics, LLC | Schnelle thermocycling-verfahren |
| US11965217B2 (en) * | 2020-07-21 | 2024-04-23 | Delta Electronics, Inc. | Method and kit for detecting Mycobacterium tuberculosis |
| US20240018585A1 (en) * | 2020-12-15 | 2024-01-18 | Gateway Genomics, Llc | Methods, compositions, and devices for the rapid determination of fetal sex |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5541331A (en) | 1991-04-30 | 1996-07-30 | Reilly Industries, Inc. | Processes for producing α-pyridyl carbinols |
| WO1997027214A1 (en) | 1996-01-24 | 1997-07-31 | Third Wave Technologies, Inc. | Invasive cleavage of nucleic acids |
| US6020124A (en) * | 1992-04-27 | 2000-02-01 | Trustees Of Dartmouth College | Detection of soluble gene sequences in biological fluids |
| JP2001507921A (ja) | 1992-04-27 | 2001-06-19 | トラスティーズ オブ ダートマス カレッジ | 生物学的液体中の遺伝子配列の検出 |
| US5614402A (en) | 1992-12-07 | 1997-03-25 | Third Wave Technologies, Inc. | 5' nucleases derived from thermostable DNA polymerase |
| US5541311A (en) | 1992-12-07 | 1996-07-30 | Third Wave Technologies, Inc. | Nucleic acid encoding synthesis-deficient thermostable DNA polymerase |
| WO1997006819A1 (en) * | 1995-08-15 | 1997-02-27 | Alteon Inc. | Compositions and methods for elmination of advanced glycosylation endproducts (in vivo) |
| DE19540222A1 (de) * | 1995-10-18 | 1997-04-24 | Horst Dr Schlechte | Verfahren und Vorrichtung zur Gewinnung Personen- und Krankheits-spezifischer Nucleinsäure-Sequenz-Daten |
-
1998
- 1998-05-29 DK DK98924998T patent/DK0920539T3/da active
- 1998-05-29 ES ES98924998T patent/ES2260837T3/es not_active Expired - Lifetime
- 1998-05-29 WO PCT/US1998/010965 patent/WO1998054364A1/en not_active Ceased
- 1998-05-29 US US09/230,704 patent/US6251638B1/en not_active Expired - Lifetime
- 1998-05-29 DE DE69833856T patent/DE69833856T2/de not_active Expired - Lifetime
- 1998-05-29 AU AU77039/98A patent/AU7703998A/en not_active Abandoned
- 1998-05-29 DK DK10161334.7T patent/DK2216416T3/da active
- 1998-05-29 EP EP98924998A patent/EP0920539B9/de not_active Expired - Lifetime
- 1998-05-29 AT AT05077010T patent/ATE486958T1/de active
- 1998-05-29 DE DE69841989T patent/DE69841989D1/de not_active Expired - Lifetime
- 1998-05-29 AT AT10161334T patent/ATE557103T1/de active
- 1998-05-29 AT AT98924998T patent/ATE320505T1/de active
- 1998-05-29 ES ES10161334T patent/ES2389055T3/es not_active Expired - Lifetime
- 1998-05-29 EP EP05077010A patent/EP1634966B1/de not_active Expired - Lifetime
- 1998-05-29 EP EP10161334A patent/EP2216416B1/de not_active Expired - Lifetime
- 1998-05-29 ES ES05077010T patent/ES2355631T3/es not_active Expired - Lifetime
- 1998-05-29 DK DK05077010.6T patent/DK1634966T3/da active
- 1998-05-29 PT PT10161334T patent/PT2216416E/pt unknown
-
2000
- 2000-07-03 US US09/609,162 patent/US6287820B1/en not_active Expired - Lifetime
-
2012
- 2012-08-08 CY CY20121100714T patent/CY1113124T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0920539T3 (da) | 2006-07-24 |
| EP0920539B9 (de) | 2006-08-02 |
| US6251638B1 (en) | 2001-06-26 |
| EP0920539A1 (de) | 1999-06-09 |
| DE69841989D1 (de) | 2010-12-16 |
| DE69833856D1 (de) | 2006-05-11 |
| ES2389055T3 (es) | 2012-10-22 |
| EP1634966A3 (de) | 2006-06-21 |
| ES2260837T3 (es) | 2006-11-01 |
| ATE557103T1 (de) | 2012-05-15 |
| EP1634966B1 (de) | 2010-11-03 |
| WO1998054364A1 (en) | 1998-12-03 |
| HK1088363A1 (en) | 2006-11-03 |
| DK1634966T3 (da) | 2011-02-07 |
| AU7703998A (en) | 1998-12-30 |
| EP0920539A4 (de) | 2004-06-09 |
| ATE320505T1 (de) | 2006-04-15 |
| EP0920539B1 (de) | 2006-03-15 |
| DK2216416T3 (da) | 2012-08-27 |
| EP2216416B1 (de) | 2012-05-09 |
| US6287820B1 (en) | 2001-09-11 |
| EP1634966A2 (de) | 2006-03-15 |
| CY1113124T1 (el) | 2016-04-13 |
| PT2216416E (pt) | 2012-08-16 |
| ES2355631T3 (es) | 2011-03-29 |
| EP2216416A1 (de) | 2010-08-11 |
| DE69833856T2 (de) | 2006-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69833856D1 (de) | Verfahren zur bestimmung von nukleinsäuresequenzen in urin | |
| DE69333289D1 (de) | Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien | |
| DK1141728T3 (da) | Påvisning af nyresygdom og behandling deraf | |
| DE60000583D1 (de) | Verfahren zur identifizierung und/oder quantifizierung einer zielverbindung | |
| ATE515693T1 (de) | Nachweis einer zielsubstanz in einer probe | |
| DE69433816D1 (de) | Die bestimmung von nukleinsäuremutationen durch analyse des sputum | |
| DE60041355D1 (de) | Verfahren zur detektion von erkrankungen | |
| DE69939121D1 (de) | Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden | |
| CA2317816A1 (en) | Peptide detection method | |
| KR960007789A (ko) | 단백질 c/단백질 s시스템의 장해를 검출하기 위한 방법 | |
| ATE333091T1 (de) | Verfahren zur messung von blutersatzstoffen | |
| DK328584A (da) | Immunobestemmelsesmetode for en iodthyronin i en biologisk vaeske samt reagenssystem, testsaet og testmateriale til anvendelse ved metoden | |
| DE59911255D1 (de) | ELISPOT-Verfahren zur Quantifizierung der Aktivität von menschlichen und tierischen Zellen, zur insbesondere Blutzellen | |
| DE60025336D1 (de) | Verfahren und kit zur früherkennung von krebs | |
| DE69524199D1 (de) | Primer und sonden zur amplifizierung und zum nachweis von cmv nukleinsäure | |
| DE60012723D1 (de) | Verfahren zur bestimmung von disaccharidasen | |
| ATE148233T1 (de) | Verfahren zur bestimmung von thrombose verursachenden lupus-anticoagulant-antikörpern | |
| DE60121547D1 (de) | Electrochemisches verfahren zum nachweis von nukleinsäuren | |
| ATE201769T1 (de) | Verfahren zur kompetitiven bestimmung eines haptens | |
| EP1580265A4 (de) | Aus einem neuroblastom in stufe 4s isoliertenukleinsäuren | |
| EP1136568A4 (de) | Methode zum ermitteln der nukleinsäure | |
| ATE485515T1 (de) | Verfahren zur diagnose einer person mit multipler sklerose | |
| ATE478147T1 (de) | Aus einem neuroblastom isolierte nukleinsäuren | |
| WO2002018661A3 (en) | Methods for identifying novel therapeutic agents | |
| ATE269971T1 (de) | Verfahren zur prüfung von immunokompetenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1634966 Country of ref document: EP |